Investigation of the effects of NT157, a multitarget anticancer drug, in lung cancer cell models (2021)
- Authors:
- USP affiliated authors: TRAINA, FABÍOLA - FMRP ; MACHADO NETO, JOÃO AGOSTINHO - ICB ; MIRANDA, LÍVIA BASSANI LINS DE - ICB ; LIMA, KELI CRISTINA DE - FM ; SILVA, JUAN LUIZ COELHO DA - FMRP
- Unidades: FMRP; ICB; FM
- DOI: 10.1111/bph.15648
- Subjects: NEOPLASIAS PULMONARES; QUIMIOTERÁPICOS; MOLÉCULAS DE ADESÃO CELULAR; ANTINEOPLÁSICOS
- Language: Inglês
- Imprenta:
- Source:
- Título: British Journal of Pharmacology
- ISSN: 1476-5381
- Volume/Número/Paginação/Ano: v. 178, n. 24, p. 4935, res. P015, 2021
- Conference titles: Annual Meeting Pharmacology 2021
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
MIRANDA, Lívia Bassani Lins De et al. Investigation of the effects of NT157, a multitarget anticancer drug, in lung cancer cell models. British Journal of Pharmacology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1111/bph.15648. Acesso em: 27 dez. 2025. , 2021 -
APA
Miranda, L. B. L. D., Lima, K., Silva, J. L. C., Traina, F., & Machado Neto, J. A. (2021). Investigation of the effects of NT157, a multitarget anticancer drug, in lung cancer cell models. British Journal of Pharmacology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1111/bph.15648 -
NLM
Miranda LBLD, Lima K, Silva JLC, Traina F, Machado Neto JA. Investigation of the effects of NT157, a multitarget anticancer drug, in lung cancer cell models [Internet]. British Journal of Pharmacology. 2021 ; 178( 24): 4935.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1111/bph.15648 -
Vancouver
Miranda LBLD, Lima K, Silva JLC, Traina F, Machado Neto JA. Investigation of the effects of NT157, a multitarget anticancer drug, in lung cancer cell models [Internet]. British Journal of Pharmacology. 2021 ; 178( 24): 4935.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1111/bph.15648 - NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells
- Metabolic adaptation and multidrug resistance in FLT3 inhibitor resistant acute myeloid leukemia
- NT157 exhibits antineoplastic effects by targeting IRS and STAT3/5 signaling in multiple myeloma
- Autophagy inhibition potentiates ruxolitinib-induced apoptosis in JAK2V617F cells
- Synthesis and evaluation of 2-substituted quinazolin-4(3H)-ones as potential antileukemic agents
- Pharmacological PIP4K2 inhibition disrupts mitochondrial homeostasis and autophagy in acute leukemia
- ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemia
- DNMT3A is highly expressed in bone marrow cells from acute myeloid leukemia patients
- Stathmin 1 expression in plasma cell neoplasms. [Carta]
- IRAK1 expression in bone marrow cells does not impact patient outcomes in myelodysplastic syndromes. [Carta]
Informações sobre o DOI: 10.1111/bph.15648 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003228762.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
